We have previously described six patients with spontaneous hypertensive ICH in whom evidence of extravasation on magnetic resonance (MR) imaging indicated active bleeding (H Yokota, et al., unpublished data). We sought to determine whether evidence of extravasation on MR imaging, that is, leakage of contrast medium from the hemorrhage site in the hyperacute stage and the presence of high-intensity areas on T 1 -weighted images, would be useful in identifying active bleeding in hypertensive ICH. As a corollary, we evaluated the absence of extravasation as an indication of hemostasis and used this as a basis for decisions concerning surgery and intensive care. Finally, we correlated the presence of extravasation on MR imaging with that on conventional cerebral angiography ( Fig. 1) .
Clinical Material and Methods

Patient Population
Two hundred eighty-eight consecutive patients treated for hypertensive ICH between 1990 and 1996 were assessed retrospectively. Patients who met the following criteria for hypertension were included in the study: the presence of hypertension based on history, prescribed medications, and/or evidence of ventricular hypertrophy on electrocardiography. Patients in whom cerebral angiography, computerized tomography (CT) scanning, or MR imaging showed an underlying intracranial lesion such as an aneurysm, vascular malformation, moyamoya disease, or brain tumor were excluded. We also excluded patients with a history of malignancy and those receiving anticoagulant medications. Patients who met the following criteria were included in this study: 1) presence of ICH on neuroimaging studies; 2) initial CT scan within 6 hours postonset and repeated CT scan within 48 hours of onset; 3) MR imaging obtained with and without gadoliniumdiethylenetriamine pentaacetic acid (Gd-DTPA) enhancement within 6 hours of onset; and 4) cerebral angiography performed within 6 hours of onset. Of the 288 patients with hypertensive ICH, 180 were excluded: 92 had been admitted more than 6 hours postictus, 34 did not undergo a repeated CT scan because of emergency surgery or hemodynamic instability, and 54 did not undergo MR imaging and/or angiography because of emergency surgery, hemodynamic instability, or our inability to obtain consent. Of the remaining 108 patients, 66 (61%) were men; the mean age was 59.3 years.
On admission, a neurological examination was performed and vital signs were recorded. The presence of ICH was confirmed on CT scans, and a calcium channel antagonist was administered to reduce the systolic blood pressure (BP) to 80% of the initial value or to keep the systolic BP below 150 mm Hg. The BP was continuously monitored for 24 hours after the onset of ICH. Venous blood was collected, and the white and red blood cell counts, platelet counts, glutamic-oxaloacetic transaminase, glutamic-pyruvic transaminase, and ␥-glutamyltranspeptidase concentrations, albumin/globulin ratio, activated partial thromboplastin and prothrombin times, and fibrinogen level were determined. Patients or their family members were interviewed concerning the patient's smoking history (cigarettes/day), alcohol consumption (g/day), and medical history. The participants were divided into groups with and without MR imaging evidence of contrast medium extravasation and were compared with respect to blood test results, alcohol consumption, smoking, and the systolic and diastolic BPs at admission and at 6 hours after onset. The study was approved by the ethics committee at our hospital and informed consent was obtained from all patients or their families.
Neuroradiological Studies
Computerized Tomography. The hematoma volume (in milliliters) on CT scans was estimated based on an ellipsoid model as follows: /6 ϫ long diameter ϫ short diameter ϫ number of slices (slice thickness was 1 cm). When intraventricular hemorrhage (IVH) was present, accurate measurement of the parenchymal hemorrhage was considered to be impossible because of the spread of blood in the cerebrospinal fluid, and the hematoma volume was not calculated. When the hematoma was irregular in shape, the volume of each portion was estimated separately. The initial CT scan was obtained at 0.5 to 3 hours (mean 1.6 hours) after onset. Repeated CT scanning was performed at the following times: 1) before surgery when surgery was clinically indicated; 2) several hours after the initial CT scan when surgery was not clinically indicated and extravasation of contrast material was detected on MR imaging; and 3) within 48 hours postictus when surgery was not clinically indicated and extravasation of contrast material was not detected on MR imaging. When expansion of the size or shape of the hematoma was detected on CT scanning, an increase in volume of at least 20 ml was defined as significant.
Magnetic Resonance Imaging. When ICH was detected on the initial CT scan, T 1 -weighted MR images with and without Gd-DTPA contrast enhancement were obtained. When extravasation of contrast medium was seen on the initial contrast-enhanced image, MR studies were repeated at approximately 12 hours postonset (range 5-24 hours, mean 10.9 hours).
The MR imaging apparatus was a 0.2-tesla superconducting unit (MRP-20; Hitachi Corp., Tokyo, Japan) with saturation recovery pulses (TR 600 msec, TE 25 msec). The contrast medium (Magnevist; Schering AG, Osaka, Japan) was injected intravenously at a rate of 10 ml per 30 seconds at doses of 0.2 ml/kg.
Cerebral Angiography. Conventional cerebral angiography was performed following CT and MR studies to confirm the presence of extravasation and also to exclude causes of hemorrhage other than hypertension (for example, vascular anomalies, cerebral aneurysms, moyamoya disease, and brain tumors). Findings on conventional angiography were correlated with the various patterns of contrast enhancement on MR imaging. Using the standard Seldinger method, the right common femoral artery was punctured, and a one-or two-vessel cerebral angiogram was obtained by means of the cut-film technique.
Selection of Treatment
Surgery for putaminal hemorrhage was indicated when the hematoma volume exceeded 30 ml and/or the patient suffered impairment of consciousness and was able to tolerate an operation. We have performed surgery in some patients harboring ICHs less than 30 ml in volume and centered in the putamen, thalamus, cerebellum, or subcortical region. We changed our criteria in 1990, after publication of the fifth Japanese cooperative study 17 reporting on its conclusions regarding the surgical indications for patients with putaminal hemorrhage. Prior to that report, we often performed surgery in patients harboring putaminal hemorrhages with volumes less than 30 ml; we treated patients with pontine or caudate nucleus hemorrhages conservatively. Patients with thalamic, cerebellar, 21 or subcortical hemorrhages underwent surgery if we observed impairment of consciousness and provided that the patient was able to tolerate an operation.
After hemostasis was confirmed on MR imaging, CTmonitored stereotactically guided aspiration of the hematoma was performed. In patients with concomitant massive IVH, ventricular drainage was also performed. Patients harboring hematomas too large or too irregular for stereotactically guided aspiration underwent cranioto-
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Extravasation on MR imaging in hypertensive intracerebral hemorrhage my. Emergency craniotomy was performed when the MR findings indicated persistent hemorrhage and CT-monitored stereotactically guided aspiration was not possible.
Statistical Analysis
Data are expressed as the mean Ϯ standard deviation (SD). Comparisons between groups were analyzed using the chi-square test.
The frequency of hematoma expansion or extravasation as seen on cerebral angiography was also compared for each pattern of contrast enhancement on MR imaging. Furthermore, the site of the hemorrhage, the actual hematoma size, and the MR findings were compared for the putamen and the thalamus. Student's t-test was used for analysis of differences between groups.
Results
There was no significant difference in the time to initial CT scan between patients with evidence of extravasation on MR imaging and those without ( Table 1 ). The time interval between the pre-and postcontrast CT studies was 7.2 to 16.7 minutes (mean 9.4 minutes). Because of the need for emergency surgery in 16 of the 58 surgically treated patients, the repeated CT scan was obtained within 8 hours; no evidence of extravasation could be demonstrated on cerebral angiography or MR imaging in 11 patients. Enlargement of the hematoma was not detected on the presurgery repeated CT scans in these patients. Repeated CT scans showed enlargement of the hematoma in three of the five remaining patients, and MR imaging in the other two showed evidence of contrast medium extravasation but no enlargement of the hematoma was seen on the repeated CT scan (obtained approximately 6.5 hours postictus). These patients were considered to have no evidence of enlargement of the hematoma.
There was evidence of contrast material extravasation on MR imaging in 39 patients, and cerebral angiography showed extravasation in 17 (Table 1 ). There was a significant correlation between extravasation on cerebral angiography and evidence of contrast medium extravasation on MR imaging (p Ͻ 0.001). Enlargement of the hematoma was detected on follow-up CT scans in 19 patients (Table 1 ) and showed a statistically significant correlation with MR imaging evidence of extravasation (p Ͻ 0.001). However, extravasation was found on cerebral angiography in two patients who did not show evidence of this condition on MR imaging. Three patients with no evidence on MR imaging of contrast medium extravasation were also found to have enlargement of the hematoma. Table 2 shows the correlation between the MR findings and hematoma enlargement and with cerebral angiography findings. The mode of contrast enhancement was classified (Fig. 2) into one of four patterns: punctate (Type A), linear (Type B), both punctate and linear (Type C), or absent (Type D). Enlargement of the hematoma was significantly more common in patients with Type A (58.3%) and Type C (30%) MR findings. Extravasation was detected on cerebral angiography in many of the patients with Type A (54.2%) and Type C (40%) MR imaging findings. Table 3 shows the correlation between the site of hemorrhage and extravasation on cerebral angiography or MR imaging. Hemorrhage affected the putamen in 57 patients, the thalamus in 34, subcortical sites in six, the cerebellum in eight, the pons in two, and the caudate nucleus in one patient. When the putamen and thalamus were compared, MR findings indicating extravasation of contrast material were seen in 23 (40.4%) of the 57 patients with hemorrhage in the putamen and enlargement of the hematoma was seen in 14 (24.6%). Among the patients with hemorrhage in the thalamus, 12 (35.3%) exhibited MR findings indicating extravasation and six (17.6%) showed hematoma enlargement; there was no significant difference between these two groups with regard to findings on MR imaging. Expansion was more common for putaminal hematomas than for those involving the thalamus. The correlation of MR findings with the laboratory and physiological data is summarized in Table  4 . There was no significant difference between patient groups with and without MR imaging evidence of contrast medium extravasation with regard to hemostatic parameters. The systolic BP at 6 hours after onset was significantly higher in the group with MR evidence of contrast material extravasation (Table 5) .
Among the 108 patients, 58 underwent surgery, and the time from onset of ictus to surgical intervention ranged from 4.5 to 31 hours (mean 10.1 hours). In 50 of these 58 patients, CT-monitored stereotactically guided aspiration was performed, and five of them also underwent ventricular drainage. Craniotomy was performed in five patients. Two patients (3.4%) showed postoperative enlargement of the hematoma. We have performed surgery in 16 patients with the Type A pattern, three patients with Type B, and five patients with Type C. We have encountered only two patients with active bleeding at surgery (Type A pattern); both of these patients had suffered putaminal hemorrhages.
Discussion
Our results indicate that evidence of contrast material extravasation on MR imaging was well correlated with hematoma enlargement and with evidence of extravasation on cerebral angiography. Therefore, such MR findings seem to indicate persistent hemorrhage and increase in the size of hematoma. Among the 39 patients with evidence of contrast material extravasation on MR imaging, 22 underwent repeated MR imaging between 5 and 24 hours after onset (mean 10.9 hours) to confirm hemostasis, and no evidence of extravasation was seen on the second image. Awareness of the possibility of enlargement of a hematoma during the acute phase is a valid basis for management decisions. Kandel and Peresedov 18 have reported that repeated hemorrhage developed in 16% of patients with hypertensive ICH, and Yamanaka and Sato 27 have reported an incidence of 4% for rehemorrhage after aspiration surgery. Yamaguchi, et al., 25 have reported that 42% of patients in whom an initial CT scan was obtained within 5 hours post-ICH showed contrast medium extravasation on angiography. In a similar study, Huckman, et al., 15 found that 12.5% showed extravasation. We have encountered only two patients (3.4%) who developed hemorrhage after aspiration surgery, which was usually performed during the acute stage. Thus, it appears reasonable to use MR imaging findings when deciding on the indications for surgery. Brott, et al., 4 have reported that growth in the hematoma volume occurred in 38% of patients with ICH. Fujii, et al., 11 have also reported that 18% of patients in whom an initial CT scan was obtained within 4 hours of the ictus showed enlargement of the hematoma on repeated scanning. In the present study we observed enlargement of the hematoma on the repeated CT scanning in 17.6% of patients in whom an initial CT scan was obtained within 3.5 hours of the ictus. The mean time to the initial CT scan was 1.59 Ϯ 1.08 hours.
Some investigators 15, 20, 22 have reported that in patients with hypertensive ICH, extravasation of contrast medium from ruptured blood vessels was a common finding on cerebral angiography performed in the hyperacute stage within a few hours postonset. Intravenously administered Gd-DTPA cannot cross the normal blood-brain barrier, and other researchers have shown that the mechanism of contrast medium leakage on MR imaging appeared to be the result of leakage from ruptured vessels similar to extravasation seen during cerebral angiography, and ischemic change of the vascular wall caused by compression by the hematoma, which increases vascular permeability and causes leakage (diapedesis) of contrast medium outside the blood vessels.
2,5 However, it is not possible to explain differences in the pattern of findings on MR imaging because the overall pathogenesis of these phenomena is not clear. It was unclear whether contrast medium was within or outside of the existing clot, especially in patients with the Type B pattern, and whether there was disruption of the blood-brain barrier at the periphery of a hematoma.
Hyperacute hematoma showed almost the same intensity as the cerebral parenchyma on MR imaging, so contrast medium extravasation was easily visualized. Mag- * Data are presented as the mean Ϯ SD. There was no significant difference in any of the parameters when patients with and without extravasation were compared. Abbreviations: APTT = activated partial thromboplastin time; ␥GTP = gamma-glutamyltranspeptidase; GOT = glutamic-oxaloacetic transaminase; GPT = glutamic-pyruvic transaminase; PTT = partial thromboplastin time; RBC = red blood cell; WBC = white blood cell. netic resonance imaging is noninvasive, an advantage over angiography, although not many institutions have the resources to perform emergency MR studies 24 hours a day.
Significance of MR Imaging Findings
When the MR findings were classified as Type A (that is, punctate contrast enhancement within the hematoma and at its margin), enlargement of the hematoma was seen in 14 of 23 patients and extravasation on cerebral angiography was found in 12. These findings were the strongest indicators of persistent hemorrhage. Yamamoto, et al., 26 have classified MR imaging findings into Type A (no contrast enhancement), Type B (punctate enhancement within the hematoma or within 5 mm of its margin), and Type C (zonal or macular contrast enhancement). As defined by Yamamoto, et al., Type C enhancement indicated continued hemorrhage, which largely corresponds to our Types A and C.
In some reports 6, 19 it has been demonstrated that the site of hemorrhage most susceptible to hematoma enlargement is the thalamus adjacent to the third ventricle. In the present study, there were no significant differences in MR findings for hemorrhage in the putamen as compared with the thalamus, although actual expansion of the hematoma was more common in the putamen. The apparent difference between our results and those of other studies may be because we excluded patients with IVH from the calculation of hematoma size. In addition, no pathological examination was performed, and the possibility exists that hemorrhage in some of our patients was caused by factors other than hypertension, such as amyloid angiopathy with subcortical hemorrhage.
Relationship With Clinical Parameters
In the hyperacute stage of hypertensive ICH, the risk factors for hematoma expansion include liver dysfunction, 5, 10, 12 excessive alcohol consumption, 8, 10, 16, 24 anticoagulant therapy, 7, 11, 16 thrombocytopenia, 2, 22 poorly controlled hypertension, 6, 7, 16, 19 the shape of the hematoma on initial CT scans, 11 and extravasation on cerebral angiography. 20, 22 In the present study, MR findings of extravasation showed significant correlation only with systolic BP at 6 hours after onset. These results may be related to the fact that we compared the MR imaging contrast-enhancement findings rather than the actual expansion of the hematoma.
